Hopman Mark sold BBNX
September 2, 2026 · Form 4 insider transaction
Hopman Mark sold 5,327 shares of Beta Bionics, Inc. at $19.11 per share, a transaction worth $101.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,327
Price
$19.11
Total value
$101.8K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 2, 2026
Filing dateSeptember 3, 2026
Shares owned after124,027
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.; The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.